Ring Christine
SEC CIK 1817199 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | GC | 14.9K | — | $5.69M | 105 | 2021-07-20 | 2026-09-02 |
Most active insiders at NRIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ring Christine | CLO | — | $3.26M |
| 2 | van Houte Hans | CFO | — | $635.3K |
| 3 | Hansen Gwenn | CSO | — | $630.9K |
Transactions 105
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-02 19:42 | 2026-09-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $8.72 | +5,787 | 14.9K | +64% | +$50.5K |
| DMT | 2026-09-02 19:42 | 2026-09-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $25.76 | -5,787 | 9,110 | -39% | -$149.1K |
| DT | 2026-08-03 17:51 | 2026-08-03 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $8.72 | +5,787 | 25.7K | +29% | +$50.5K |
| DT | 2026-08-03 17:51 | 2026-08-03 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $23.05 | -16.6K | 9,110 | -65% | -$382.4K |
| DM | 2026-07-30 17:56 | 2026-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +10.2K | 23.8K | +75% | $0 |
| D | 2026-07-30 17:56 | 2026-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $23.38 | -3,847 | 19.9K | -16% | -$90.0K |
| DMT | 2026-07-02 18:02 | 2026-07-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $5.47 | +11.0K | 24.6K | +81% | +$60.2K |
| DT | 2026-07-02 18:02 | 2026-07-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $23.56 | -11.0K | 13.6K | -45% | -$259.4K |
| DMT | 2026-06-25 18:38 | 2026-06-25 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $8.05 | +28.9K | 42.5K | +213% | +$232.8K |
| DT | 2026-06-25 18:38 | 2026-06-25 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $20.06 | -28.9K | 13.6K | -68% | -$580.5K |
| DT | 2026-06-02 19:14 | 2026-06-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +3,422 | 21.7K | +19% | +$6,365 |
| DT | 2026-06-02 19:14 | 2026-06-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $16.60 | -8,148 | 13.6K | -38% | -$135.3K |
| T | 2026-05-04 18:10 | 2026-05-04 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale | $16.96 | -8,148 | 18.3K | -31% | -$138.2K |
| T | 2026-05-01 17:50 | 2026-05-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale | $16.76 | -5,394 | 26.5K | -17% | -$90.4K |
| DM | 2026-04-30 17:37 | 2026-04-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +8,608 | 35.1K | +33% | $0 |
| D | 2026-04-30 17:37 | 2026-04-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $16.65 | -3,214 | 31.8K | -9% | -$53.5K |
| T | 2026-04-02 19:02 | 2026-04-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale | $15.24 | -8,148 | 26.5K | -24% | -$124.1K |
| 2026-03-02 | 2026-03-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale | $15.44 | -8,148 | 34.6K | -19% | -$125.8K | |
| 2026-02-09 | 2026-02-09 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale | $16.66 | -14.3K | 42.7K | -25% | -$237.6K | |
| DM | 2026-01-30 | 2026-01-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +10.5K | 58.6K | +22% | $0 |
| DM | 2026-01-30 | 2026-01-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $16.60 | -4,421 | 57.1K | -7% | -$73.4K |
| D | 2026-01-20 | 2026-01-20 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +3,760 | 54.7K | +7% | +$6,994 |
| D | 2026-01-20 | 2026-01-20 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $18.42 | -3,760 | 50.9K | -7% | -$69.3K |
| DM | 2025-12-18 | 2025-12-18 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $17.91 | -3,760 | 50.9K | -7% | -$67.3K |
| D | 2025-12-18 | 2025-12-18 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +3,760 | 54.7K | +7% | +$6,994 |
| D | 2025-11-24 | 2025-11-24 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $17.07 | -37.6K | 50.9K | -42% | -$641.8K |
| D | 2025-11-24 | 2025-11-24 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +37.6K | 88.5K | +74% | +$69.9K |
| DM | 2025-10-30 | 2025-10-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +10.5K | 51.7K | +26% | $0 |
| D | 2025-10-30 | 2025-10-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $12.80 | -3,644 | 50.9K | -7% | -$46.6K |
| D | 2025-07-30 | 2025-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $12.01 | -3,841 | 44.0K | -8% | -$46.1K |
| DM | 2025-07-30 | 2025-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +10.5K | 41.2K | +34% | $0 |
| DM | 2025-04-30 | 2025-04-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +7,674 | 34.5K | +29% | $0 |
| D | 2025-04-30 | 2025-04-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $11.50 | -2,894 | 37.3K | -7% | -$33.3K |
| DM | 2025-02-03 | 2025-01-31 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 38.3K | +18% | +$10.7K |
| DM | 2025-02-03 | 2025-01-31 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $19.95 | -5,760 | 32.6K | -15% | -$114.9K |
| DM | 2025-01-30 | 2025-01-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +7,674 | 30.0K | +34% | $0 |
| DM | 2025-01-30 | 2025-01-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $19.86 | -3,220 | 32.8K | -9% | -$63.9K |
| D | 2025-01-02 | 2025-01-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 33.8K | +21% | +$10.7K |
| D | 2025-01-02 | 2025-01-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $19.50 | -5,760 | 28.1K | -17% | -$112.3K |
| D | 2024-12-02 | 2024-12-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $21.73 | -5,760 | 28.1K | -17% | -$125.2K |
| D | 2024-12-02 | 2024-12-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 33.8K | +21% | +$10.7K |
| D | 2024-11-04 | 2024-11-04 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $25.00 | -3,290 | 28.1K | -10% | -$82.2K |
| D | 2024-11-04 | 2024-11-04 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $9.57 | +3,290 | 31.4K | +12% | +$31.5K |
| D | 2024-11-01 | 2024-11-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $24.28 | -5,760 | 28.1K | -17% | -$139.9K |
| D | 2024-11-01 | 2024-11-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 33.8K | +21% | +$10.7K |
| D | 2024-10-30 | 2024-10-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $24.31 | -4,182 | 28.1K | -13% | -$101.7K |
| DM | 2024-10-30 | 2024-10-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +7,674 | 26.5K | +41% | $0 |
| D | 2024-10-15 | 2024-10-14 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $25.00 | -3,290 | 24.6K | -12% | -$82.2K |
| D | 2024-10-15 | 2024-10-14 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $9.57 | +3,290 | 27.9K | +13% | +$31.5K |
| D | 2024-10-01 | 2024-10-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 30.4K | +23% | +$10.7K |
| DM | 2024-10-01 | 2024-10-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $22.22 | -5,760 | 24.6K | -19% | -$128.0K |
| DM | 2024-09-03 | 2024-09-03 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $24.95 | -9,050 | 24.8K | -27% | -$225.8K |
| DM | 2024-09-03 | 2024-09-03 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $4.66 | +9,050 | 30.4K | +42% | +$42.2K |
| D | 2024-08-26 | 2024-08-26 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $25.01 | -9,870 | 24.6K | -29% | -$246.8K |
| DM | 2024-08-26 | 2024-08-26 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $6.08 | +9,870 | 29.1K | +51% | +$60.0K |
| DM | 2024-08-01 | 2024-08-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $21.43 | -5,760 | 24.6K | -19% | -$123.4K |
| D | 2024-08-01 | 2024-08-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 30.4K | +23% | +$10.7K |
| D | 2024-07-30 | 2024-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $20.67 | -2,920 | 24.6K | -11% | -$60.4K |
| DM | 2024-07-30 | 2024-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +7,674 | 21.8K | +54% | $0 |
| D | 2024-07-01 | 2024-07-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 25.6K | +29% | +$10.7K |
| DM | 2024-07-01 | 2024-07-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $20.80 | -5,760 | 20.6K | -22% | -$119.8K |
| D | 2024-06-13 | 2024-06-13 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $17.02 | -1,864 | 19.8K | -9% | -$31.7K |
| D | 2024-06-13 | 2024-06-13 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +1,864 | 21.7K | +9% | +$3,467 |
| D | 2024-06-12 | 2024-06-12 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $17.01 | -1,900 | 19.8K | -9% | -$32.3K |
| D | 2024-06-12 | 2024-06-12 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +1,900 | 21.7K | +10% | +$3,534 |
| D | 2024-06-05 | 2024-06-05 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +400 | 20.2K | +2% | +$744 |
| D | 2024-06-05 | 2024-06-05 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $17.00 | -400 | 19.8K | -2% | -$6,800 |
| D | 2024-06-03 | 2024-06-03 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $1.86 | +1,596 | 21.4K | +8% | +$2,969 |
| D | 2024-06-03 | 2024-06-03 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $17.01 | -1,596 | 19.8K | -7% | -$27.1K |
| DM | 2024-04-30 | 2024-04-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +3,924 | 19.4K | +25% | $0 |
| D | 2024-04-30 | 2024-04-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $12.04 | -1,513 | 19.8K | -7% | -$18.2K |
| D | 2024-01-30 | 2024-01-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $7.99 | -1,760 | 17.4K | -9% | -$14.1K |
| DM | 2024-01-30 | 2024-01-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +3,924 | 17.2K | +30% | $0 |
| D | 2023-11-01 | 2023-10-31 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | S - Sale+OE | $5.20 | -1,232 | 15.3K | -7% | -$6,406 |
| DM | 2023-11-01 | 2023-10-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | CLO | M - OptEx | $0.00 | +3,924 | 16.5K | +31% | $0 |
| DM | 2023-08-01 | 2023-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $0.00 | +3,924 | 12.0K | +49% | $0 |
| D | 2023-08-01 | 2023-07-31 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $9.65 | -1,420 | 12.5K | -10% | -$13.7K |
| D | 2023-05-02 | 2023-04-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 10.7K | +22% | $0 |
| D | 2023-05-02 | 2023-05-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $9.88 | -682 | 10.0K | -6% | -$6,738 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $11.78 | -848 | 7,261 | -10% | -$9,989 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 8,109 | +31% | $0 |
| D | 2022-11-01 | 2022-10-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 6,884 | +39% | $0 |
| D | 2022-11-01 | 2022-10-31 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $12.88 | -699 | 6,185 | -10% | -$9,003 |
| D | 2022-08-02 | 2022-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 5,327 | +57% | $0 |
| D | 2022-08-02 | 2022-08-01 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $15.67 | -712 | 4,615 | -13% | -$11.2K |
| D | 2022-05-03 | 2022-04-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 4,063 | +90% | $0 |
| D | 2022-05-03 | 2022-05-02 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $11.75 | -660 | 3,403 | -16% | -$7,755 |
| D | 2022-01-11 | 2022-01-10 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2022-01-11 | 2022-01-10 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $27.14 | -1,200 | 1,286 | -48% | -$32.6K |
| D | 2021-12-13 | 2021-12-10 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $29.04 | -1,200 | 1,286 | -48% | -$34.8K |
| D | 2021-12-13 | 2021-12-10 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2021-11-12 | 2021-11-10 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2021-11-12 | 2021-11-10 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $32.38 | -1,200 | 1,286 | -48% | -$38.9K |
| D | 2021-10-28 | 2021-10-27 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $1.86 | +800 | 2,086 | +62% | +$1,488 |
| D | 2021-10-28 | 2021-10-27 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $35.25 | -800 | 1,286 | -38% | -$28.2K |
| D | 2021-10-12 | 2021-10-11 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2021-10-12 | 2021-10-11 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $27.36 | -1,200 | 1,286 | -48% | -$32.8K |
| D | 2021-09-13 | 2021-09-10 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $1.86 | +2,000 | 3,286 | +156% | +$3,720 |
| DM | 2021-09-13 | 2021-09-10 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $35.93 | -2,000 | 1,286 | -61% | -$71.9K |
| D | 2021-09-08 | 2021-09-07 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | M - OptEx | $1.86 | +3,200 | 4,486 | +249% | +$5,952 |
Purchase Sale Sale after option exercise All abbreviations